BioCryst Pharmaceuticals | BCRX - PE Price to Earnings


BioCryst Pharmaceuticals reported 6.06 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Chugai Pharma 28.87 2.38 Mar/2026
Daiichi Sankyo 20.73 1.74 Dec/2025
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Dec/2025
Vertex Pharmaceuticals 25.82 0.33 Mar/2026